We support pharma and biotech partners with customer-centric companion diagnostics solutions.
We provide companion diagnostics services for all stages of drug and therapy development programs from biomarker discovery and target validation during early stages to custom assay development for later stages, and commercialization and regulatory support.
We offer a variety of services to support your programs with the discovery of biomarkers including whole genome, whole exome and targeted sequencing, single cell sequencing, genotyping and gene expression analysis. Whether you are doing basic research on some model organism or conducting pre-clinical or clinical studies, you can count on our in-depth experience and expertise to make your project a success.
Custom Assay Development
We have over 10 years of experience in the development of custom NGS assays with high sensitivity and specificity. We can support your therapy development programs with NGS assays targeted to your genomic regions of interest to capture high quality genetic information at low costs. If short development time is a priority, we can build virtual panels based on WGS or WES data to support your research programs. Our experts can advise you on the best solution for your needs.
We have the required legal, regulatory, and commercial expertise and experience to bring your CDx assays to market in Europe. We are supporting several international partners to bring assays developed in USA or elsewhere and implement them in our Medicover network of laboratories.